Log in to save to my catalogue

Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juve...

Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juve...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_02da6ee1170941e6b87a76b7b20a3828

Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study

About this item

Full title

Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study

Publisher

London: BioMed Central Ltd

Journal title

Pediatric Rheumatology, 2022-11, Vol.20 (1), p.1-96, Article 96

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Etanercept (ETN) and adalimumab (ADA) are considered equally effective biologicals in the treatment of arthritis in juvenile idiopathic arthritis (JIA) but no studies have compared their impact on patient-reported well-being. The objective of this study was to determine whether ETN and ADA have a differential effect on patient-reported w...

Alternative Titles

Full title

Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_02da6ee1170941e6b87a76b7b20a3828

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_02da6ee1170941e6b87a76b7b20a3828

Other Identifiers

ISSN

1546-0096

E-ISSN

1546-0096

DOI

10.1186/s12969-022-00763-x

How to access this item